openPR Logo
Press release

Bronchiectasis Therapeutics Pipeline - Key Players Analysis Aradigm Corporation, Bayer, Zambon

11-30-2018 08:54 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Bronchiectasis Therapeutics Pipeline - Key Players Analysis

The study analysed that the Bronchiectasis therapeutics pipeline comprises approximately 13 drug candidates in different stages of development.

Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways from clearing mucus. In bronchiectasis, the airways slowly lose their ability to clear out mucus. When mucus cannot be cleared, it builds up and creates an environment in which bacteria can grow. This leads to frequent and serious lung infections.

Download report sample at: https://www.psmarketresearch.com/market-analysis/bronchiectasis-therapeutics-pipeline-analysis/report-sample

*Synthetic sources being used for the development of drugs

The research also found that there are several companies that use synthetic sources for the development of drugs for the treatment of bronchiectasis.

Some of the other key players developing drugs for the treatment of bronchiectasis include Aradigm Corporation, Bayer AG, Zambon SpA and others.

Browse Report at: https://www.psmarketresearch.com/market-analysis/bronchiectasis-therapeutics-pipeline-analysis

*Various technology platform for bronchiectasis drug development

Insmed’s liposomal technology is designed specifically for the delivery of pharmaceuticals to the lung. Liposomes are the microscopic membrane shells that contain water. In a liposome drug delivery system, water-soluble drugs such as amikacin, are located in the liposome’s water core. The liposome delivery system delivers medicine directly to the site of the lung infection. The infecting bacteria invade and multiply mainly within macrophages. The materials found in a patient’s mucus and biofilms that are produced by bacteria to protect themselves have negative charges which attracts opposite charged antibiotics such as amikacin.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchiectasis Therapeutics Pipeline - Key Players Analysis Aradigm Corporation, Bayer, Zambon here

News-ID: 1411650 • Views: 721

More Releases from P&S Intelligence

Data Center Colocation Market | Covid19 Impact Analysis | Business Outlook, Grow …
Large enterprises are currently the larger users of colocation services, on account of their desire to decrease their operational expenses and increase focus on their more-critical areas. This is being done by giving the responsibility to house their expensive information technology (IT) hardware, such as routers, modems, and servers, to data centers, which also let them store huge amounts of data. Get the Sample Copy of this Report at:https://www.psmarketresearch.com/market-analysis/data-center-colocation-market/report-sample In addition, as
How Surging Interaction Through Enterprise Messaging Applications Driving Key Ma …
In the wake of the rising cyber attacks, adoption of cloud technologies, and focus on digital transformation, the need to meet the associated regulatory compliance is increasing around the world. Health Insurance Portability and Accountability Act (HIPAA), Payment Card Industry Data Security Standard (PCI DSS), General Data Protection Regulation (GDPR), and Federal Information Security Management Act (FISMA) are the various acts and standards which govern cyber security. Get the Sample Copy
Digital Out of Home Market Growth Declines, However COVID-19 Pandemic May Bring …
Digital out of home or DOOH refers to digital media displayed in outdoors that is accessible to the public and used for advertising and marketing purposes. It is displayed via electronic displays in a variety of formats, excluding radio and TV advertising. It consists of digital billboards, out of home (OOH) displays, digital signages, LEDs, and screen technologies. Request Sample Copy of Report : https://www.psmarketresearch.com/market-analysis/digital-out-of-home-market/report-sample The digital out of home market is
Medical Device Outsourcing Market - Future Developments, Trends, and Opportunity …
The healthcare industry is witnessing rapid growth because of the surging prevalence of diseases all across the world. The medical industry does not only deal with drugs and therapy, but medical devices are an important part of it. Attributed to this, the medical devices industry is registering swift growth as well. In 2018, the global medical devices market attained a value of $425.5 billion and is predicted to reach $612.7

All 5 Releases


More Releases for Bronchiectasis

Bronchiectasis Global Market Research Report 2025
Bronchiectasis Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/bronchiectasis-market/80987 The report firstly introduced the Bronchiectasis basics: definitions, classifications, applications and market overview; product
Bronchiectasis - Market Insights, Epidemiology and Market Forecast 2018-2027
Bronchiectasis Market: WiseGuyReports.com adds “Bronchiectasis Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2027” reports tits database. Executive Summary “Bronchiectasis - Market Insights, Epidemiology and Market Forecast – 2027” report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market
Bronchiectasis Therapeutics Analysis - Clinical Trials & Results, Collaboration …
The study analysed that the Bronchiectasis therapeutics pipeline comprises approximately 13 drug candidates in different stages of development. Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways
Global Bronchiectasis Treatment Market Review 2018-2023 Insmed, Bayer, Recipharm
A market study "Global Bronchiectasis Treatment Market" examines the performance of the Bronchiectasis Treatment market 2018. It encloses an in-depth Research of the Bronchiectasis Treatment market state and the competitive landscape globally. This report analyzes the potential of Bronchiectasis Treatment market in the present and the future prospects from various angles in detail. The Global Bronchiectasis Treatment Market 2018 report includes Bronchiectasis Treatment market Revenue, market Share, Bronchiectasis Treatment industry volume,
Bronchiectasis Treatment Market Trends Detailed in New Research Report 2025
Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in serious health conditions such as heart failure and respiratory failure. Mucus producing cough is the major symptom of this condition. Request Report for Table of Contents
Bronchiectasis Therapeutics Clinical Trials, Pipeline Analysis & Collaboration
Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways from clearing mucus. In bronchiectasis, the airways slowly lose their ability to clear out mucus. When mucus cannot